NZ744342A - Probiotics for use as anti-inflammatory agents in the oral cavity - Google Patents

Probiotics for use as anti-inflammatory agents in the oral cavity

Info

Publication number
NZ744342A
NZ744342A NZ744342A NZ74434217A NZ744342A NZ 744342 A NZ744342 A NZ 744342A NZ 744342 A NZ744342 A NZ 744342A NZ 74434217 A NZ74434217 A NZ 74434217A NZ 744342 A NZ744342 A NZ 744342A
Authority
NZ
New Zealand
Prior art keywords
oral cavity
lactobacillus
present
cctcc
dsm
Prior art date
Application number
NZ744342A
Other languages
English (en)
Inventor
Marcus Rudolf Götz
Kerstin Holmgren
Niklas Larsson
Bernd Fiebich
William Wade
Original Assignee
Symrise Ag
Probi Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Symrise Ag, Probi Ab filed Critical Symrise Ag
Publication of NZ744342A publication Critical patent/NZ744342A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Birds (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NZ744342A 2016-01-19 2017-01-18 Probiotics for use as anti-inflammatory agents in the oral cavity NZ744342A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16151975 2016-01-19
PCT/EP2017/051005 WO2017125447A1 (en) 2016-01-19 2017-01-18 Probiotics for use as anti-inflammatory agents in the oral cavity

Publications (1)

Publication Number Publication Date
NZ744342A true NZ744342A (en) 2022-11-25

Family

ID=55237502

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ744342A NZ744342A (en) 2016-01-19 2017-01-18 Probiotics for use as anti-inflammatory agents in the oral cavity

Country Status (8)

Country Link
US (1) US11020441B2 (enExample)
EP (1) EP3405205B1 (enExample)
JP (2) JP7065776B2 (enExample)
KR (1) KR102852714B1 (enExample)
CN (1) CN109069556B (enExample)
AU (1) AU2017209868B2 (enExample)
NZ (1) NZ744342A (enExample)
WO (1) WO2017125447A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2017209868B2 (en) 2016-01-19 2023-08-03 Probi Ab Probiotics for use as anti-inflammatory agents in the oral cavity
EP3196318A1 (en) 2016-01-19 2017-07-26 Symrise AG Probiotics for altering the composition of oral biofilms
EP3351259A1 (en) 2017-01-18 2018-07-25 Symrise AG Probiotics for aggregation with disease-associated species in the oral cavity
PL3494805T3 (pl) 2017-12-08 2025-10-06 Chr. Hansen HMO GmbH Suszone rozpyłowo tetrasacharydy
ES3039971T3 (en) 2017-12-08 2025-10-28 Chr Hansen Hmo Gmbh Spray-dried 3-fucosyllactose
EP4733390A3 (en) * 2018-05-09 2026-07-15 Kobiolabs, Inc. Lactobacillus paracasei strain and use thereof
WO2020001747A1 (en) * 2018-06-26 2020-01-02 Symrise Ag Lactobacillus plantarum for skin care
GB201908154D0 (en) * 2019-06-07 2019-07-24 Probi Ab Lactobacillus compositions and uses thereof
CN111904985B (zh) * 2020-09-15 2021-10-22 广东南芯医疗科技有限公司 副干酪乳杆菌L.p R3-10在制备预防或治疗口腔炎症性疾病药物中的应用
JP7884920B2 (ja) * 2021-06-30 2026-07-06 サンスター株式会社 乳酸菌含有組成物
CN113881751A (zh) * 2021-09-23 2022-01-04 温州医科大学附属第二医院（温州医科大学附属育英儿童医院） 口腔菌液载体的应用
CN113832062B (zh) * 2021-09-27 2022-10-28 微康益生菌(苏州)股份有限公司 一种副干酪乳杆菌lc86及其在预防或治疗龋齿和牙周炎上的应用
CN113712841B (zh) * 2021-11-01 2022-02-11 深圳市萱嘉生物科技有限公司 一种甘油葡萄糖苷在制备口腔护理产品中的应用
JP7814921B2 (ja) * 2021-12-24 2026-02-17 サンスター株式会社 乳酸菌含有組成物
CN114606164B (zh) * 2022-04-08 2024-03-15 云南白药集团股份有限公司 一株副干酪乳杆菌Probio-01及其制备益生菌口腔制剂的用途
CN114796287A (zh) * 2022-06-09 2022-07-29 比菲德(北京)生物科技有限公司 一种可预防龋齿和清新口腔的益生菌粉及其应用
US20240091135A1 (en) * 2022-09-17 2024-03-21 Reshma N. Kheraj Compositions and methods for promoting oral health
CN116694525B (zh) * 2023-06-14 2024-08-06 南昌大学 一株植物乳杆菌及其在制备抑制或缓解或治疗口腔粘膜炎菌剂的应用
CN118141739B (zh) * 2024-03-08 2024-08-02 广州壹选日化科技有限公司 一种美白抗过敏牙膏的制备方法

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4518615A (en) 1983-08-23 1985-05-21 Warner-Lambert Company Non-adhesive chewing gum base composition
US4721620A (en) 1986-04-01 1988-01-26 Warner-Lambert Company Polyvinylacetate bubble gum base composition
US5093136A (en) 1991-05-08 1992-03-03 Nabisco Brands, Inc. Dual gum base bubble gum
US5266336A (en) 1991-11-12 1993-11-30 Wm. Wrigley Jr. Company High flavor impact non-tack chewing gum with reduced plasticization
US5601858A (en) 1994-12-29 1997-02-11 Warner-Lambert Company Non-stick chewing gum
IT1306716B1 (it) 1999-06-21 2001-10-02 Mendes S U R L Associazione di batteri lattici e suo uso per la prevenzione e/o iltrattamento terapeutico di infezioni e di stati infiammatori.
US8283135B2 (en) * 2000-06-30 2012-10-09 The Procter & Gamble Company Oral care compositions containing combinations of anti-bacterial and host-response modulating agents
US6986709B2 (en) 2001-09-21 2006-01-17 Igt Gaming device having games with variable game functions
US20040101495A1 (en) 2002-11-27 2004-05-27 Leena Nase Method for improving dental health
US20050281756A1 (en) * 2004-06-14 2005-12-22 Eamonn Connolly Use of lactic acid bacteria for decreasing gum bleeding and reducing oral inflammation
EP1634948A1 (en) 2004-09-10 2006-03-15 Basf Aktiengesellschaft Means and methods for preventing and/or treating caries
SE528382C2 (sv) * 2004-10-05 2006-10-31 Probi Ab Probiotiska lactobacillusstammar för förbättrad vaginal hälsa
SE529199C2 (sv) * 2005-07-05 2007-05-29 Probi Ab Förstärkt absorption
EP1934328A1 (en) 2005-09-19 2008-06-25 Basf Se Microorganisms inhibiting the formation of foot malodor
KR101300086B1 (ko) * 2005-10-06 2013-08-30 프로비 아베 자가면역질환의 치료를 위한 락토바실러스의 용도
EP2046352A4 (en) 2006-06-06 2012-03-21 Univ Mcgill Fermented milk product and use thereof
CN101190239B (zh) 2006-11-28 2010-11-03 景岳生物科技股份有限公司 含有类干酪乳杆菌的产品
WO2008074473A2 (en) 2006-12-19 2008-06-26 Basf Se Uses and methods for preventing and/or treating caries caused by mutants streptococci
RU2009133376A (ru) 2007-03-27 2011-05-10 Дзе Проктер Энд Гэмбл Компани (US) Способы и наборы для введения пробиотиков
CN102123604A (zh) 2008-06-24 2011-07-13 Wm.雷格利Jr.公司 益生菌口香糖的制造方法
WO2010064373A1 (ja) 2008-12-04 2010-06-10 国立大学法人広島大学 Ｉｌ－８阻害剤およびその製造方法
JP2012512171A (ja) 2008-12-16 2012-05-31 ネステク ソシエテ アノニム 改善された口腔健康のための組成物及び方法
ES2778836T3 (es) * 2009-03-05 2020-08-12 Probiotical Spa Cepas de bacterias que tienen una alta actividad antiinflamatoria
DK2455095T3 (en) 2009-07-16 2017-07-24 Univ Hiroshima PROPHYLACTIC, IMPROVING OR THERAPEUTIC AGENT FOR ORAL DISEASES
DE202009011370U1 (de) 2009-08-21 2009-11-19 Dreyer Gmbh Vorrichtung zur Oberflächenbehandlung einer sich bewegenden Kunststoffschicht
DE202009011379U1 (de) 2009-08-24 2010-12-30 Khalifa, Samir Orale Präparate zur Mund- und Zahnpflege und Bekämpfung von Mundgeruch
CN101715908A (zh) 2009-12-11 2010-06-02 江南大学 一种提高益生菌清除微囊藻毒素效率的方法
CN101703179A (zh) 2009-12-11 2010-05-12 江南大学 一种清除食品中微囊藻毒素的方法
DK2364712T3 (da) 2010-03-11 2013-05-21 Kloarys Invest Ltd Topisk, kosmetisk eller farmaceutisk sammensætning, der omfatter probiotiske Lactobacillus-stammer, og anvendelse heraf
EP2420580A1 (en) * 2010-08-18 2012-02-22 AB-Biotics, S.A. Probiotic composition for oral health
TWI572354B (zh) 2010-09-09 2017-03-01 明治股份有限公司 抑制發炎之組成物
US9308227B2 (en) * 2011-05-16 2016-04-12 Organobalance Medical Ag Lactic acid bacteria and compositions containing them against bacterial colds
JP5904028B2 (ja) 2012-06-19 2016-04-13 ライオン株式会社 乳酸菌及びその培養由来物、ならびにこれらを含有する組成物
CA2783414A1 (en) 2012-07-22 2014-01-22 Integral Medical Inc. Probiotic composition
RU2492851C1 (ru) 2012-08-02 2013-09-20 Сергей Владимирович Кузнецов Способ профилактики и лечения воспаления в ротовой полости после стоматологической хирургической операции
EP2968422A1 (en) 2013-03-14 2016-01-20 Nestec S.A. Lactobacillus plantarum ncc 2936 preparations and oral health
US9587284B2 (en) 2014-02-21 2017-03-07 Asian Probiotics and Prebiotics Ltd. Lactic acid bacterium having immunomodulatory and anti-allergic effects and pharmaceutical composition containing the same
TWI505832B (zh) 2014-02-21 2015-11-01 Genmont Biotech Inc 乳酸菌、其組合物與彼等於治療自體免疫疾病暨其倂發症之用途
US9399048B2 (en) 2014-03-05 2016-07-26 Asian Probiotics And Prebiotics Ltd Lactic acid bacteria and its applications in immunomodulation and anti-inflammation
KR101825667B1 (ko) 2014-09-30 2018-02-06 주식회사 알엔에이 비배당체가 세포내에 축적되어 있는 미생물 제제의 제조방법 및 이에 의해 제조된 미생물 제제
JP2018532696A (ja) 2015-08-25 2018-11-08 カレイド・バイオサイエンシズ・インコーポレイテッド グリカン組成物およびその使用
AU2017209868B2 (en) 2016-01-19 2023-08-03 Probi Ab Probiotics for use as anti-inflammatory agents in the oral cavity
EP3196318A1 (en) 2016-01-19 2017-07-26 Symrise AG Probiotics for altering the composition of oral biofilms
GB201600975D0 (en) * 2016-01-19 2016-03-02 Probi Ab Novel strain of probiotic bacteria and compositions and uses thereof

Also Published As

Publication number Publication date
EP3405205B1 (en) 2020-07-15
KR20180102655A (ko) 2018-09-17
JP7313418B2 (ja) 2023-07-24
KR102852714B1 (ko) 2025-08-29
JP2022031608A (ja) 2022-02-21
EP3405205A1 (en) 2018-11-28
WO2017125447A1 (en) 2017-07-27
JP7065776B2 (ja) 2022-05-12
AU2017209868A1 (en) 2018-08-02
BR112018014545A2 (pt) 2018-12-11
US11020441B2 (en) 2021-06-01
CN109069556A (zh) 2018-12-21
US20190388485A1 (en) 2019-12-26
JP2019502737A (ja) 2019-01-31
HK1259171A1 (en) 2019-11-29
CN109069556B (zh) 2022-11-25
AU2017209868B2 (en) 2023-08-03

Similar Documents

Publication Publication Date Title
Sharma et al. Antibiotic resistance among commercially available probiotics
FI3016667T3 (fi) Probioottisia bakteerikantoja suuontelon sairauksien ehkäisemiseen ja hoitamiseen
JP2013535226A5 (enExample)
KR102852714B1 (ko) 구강 내 항-염증제로서 프로바이오틱스의 용도
AU2011298235B2 (en) Anticaries compositions and probiotics/prebiotics
PT1485463E (pt) Estirpes de lactobacillus
MX346458B (es) Composicion probiotica para la salud bucal.
PH12018502042B1 (en) Use of probiotics in the treatment and/or prevention of psoriasis
JP2012110334A5 (enExample)
PH12021553242A1 (en) Novel probiotic composition for regulation of intestinal immunity
PH12018550110B1 (en) Novel probiotic bacterial strain of lactobacillus plantarum and compositions and uses thereof in the treatment of inflammation
RU2011139211A (ru) Бактериальные штаммы, обладающие высокой противовоспалительной активностью
PL2309870T3 (pl) Izolowany szczep mikroorganizmu lactobacillus plantarum tensia dsm 21380 jako przeciwdrobnoustrojowy i przeciwnadciśnieniowy probiotyk, produkt spożywczy i kompozycja zawierająca wspomniany mikroorganizm oraz zastosowanie wspomnianego mikroorganizmu do wytwarzania leku przeciwnadciśnieniowego oraz sposób tłumienia patogenów i nie-starterowych pałeczek kwasu mlekowego w produkcie spożywczym
UA115520C2 (uk) Дієтична або фармацевтична композиція на основі лактобацил для вагінального або перорального введення
SE0400355D0 (sv) New synbiotec use
UA113399C2 (xx) Штам непатогенної грамнегативної бактерії та його застосування в дерматології
WO2015121458A3 (fr) Utilisations de compositions comprenant du bifidobacterium animalis ssp. lactis lmg p-28149
HRPK20130487B3 (hr) Formulacija probiotika s apigeninom i ekstraktom paprene metvice
EP3453394A3 (en) Oral and intestinal health products
PL4429686T3 (pl) Kompozycje postbiotyczne zawierające b. longum cect-7347 i l. rhamnosus cect-8361 oraz ich zastosowania terapeutyczne
WO2005112976A3 (en) Probiotic compounds from lactobacillus gg and uses therefor
WO2014096083A3 (fr) Utilisation de microorganismes probiotiques comme agent favorisant la synthèse de mélanine
Söderling Probiotics and dental caries
MX2020013860A (es) Composiciones probioticas y sus usos.
Agarwal et al. Probiotics and oral health: a review

Legal Events

Date Code Title Description
ERR Error or correction

Free format text: THE MISSING AGENT HAS BEEN ADDED (600365, PIPERS, 1ST FLOOR, IMAGETEXT HOUSE, 3 OWENS ROAD, EPSOM, AUCKLAND 1023, NZ); THE OWNER HAS BEEN CORRECTED TO 3624986, SYMRISE AG, MA HLENFELDSTRAA E 137603 HOLZMINDEN, , DE; 3624987, PROBI AB, SA LVEGATAN 41223 70 LUND, , SE

Effective date: 20211208

PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 18 JAN 2025 BY PAVIS GMBH

Effective date: 20240103

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 18 JAN 2026 BY PAVIS PAYMENTS GMBH

Effective date: 20250102